| 注册
首页|期刊导航|中国临床药理学杂志|阿托伐他汀的药物基因组学研究进展

阿托伐他汀的药物基因组学研究进展

贺宝霞 石磊 赵树进

中国临床药理学杂志2011,Vol.27Issue(11):888-891,4.
中国临床药理学杂志2011,Vol.27Issue(11):888-891,4.

阿托伐他汀的药物基因组学研究进展

Advances in search for pharmacogenomics of atorvastatin

贺宝霞 1石磊 2赵树进2

作者信息

  • 1. 河南省肿瘤医院药剂科,郑州 450008
  • 2. 广州军区广州总医院药学部,广州 510010
  • 折叠

摘要

Abstract

Atorvastatin is widely used as an oral lipid - lowering drug and it has an important role in the prevention of coronary heart disease. However, wide interindividual variations exist in the plasma lipid response to statin treatment including atorvastatin, which may due to drug - related gene polymorphism. This review states the effect of gene polymorphism on the aspect of metabolism, transportation, receptor, and adverse effect based on literature and cases in recent years, which can help provide reference for individualized treatment.

关键词

阿托伐他汀/基因多态性/药物基因组学

Key words

atorvastatin/ genetic polymorphism/ pharmacogenomics

分类

医药卫生

引用本文复制引用

贺宝霞,石磊,赵树进..阿托伐他汀的药物基因组学研究进展[J].中国临床药理学杂志,2011,27(11):888-891,4.

基金项目

广东省科技计划基金资助项目(2009B080701105) (2009B080701105)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文